Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03030131 |
|---|---|
| Brief Title: | Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer (IONESCO) |
| First Submitted : | January 12, 2017 |
| First Submitted that Met QC Criteria : | January 20, 2017 |
| First Posted : | January 24, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 8, 2020 |
| Last Update Posted : | April 10, 2020 |